Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery

Immunohematology

Volumn 20, Issue 1, 2004, Pages 63-66

  Shariatmadar, Sherry ^a   Storry, Jill R ^b,c   Sausais, Laima ^b   Reid, Marion E ^b  

^a JACKSON MEMORIAL HOSPITAL   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cefotetan; Cesarean delivery; DAT; Drug induced hemolytic anemia; Immune hemolytic anemia

Indexed keywords

CEFOTETAN; CEPHALOSPORIN DERIVATIVE; IMMUNOGLOBULIN G;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DISEASE SEVERITY; DYSPNEA; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; FATIGUE; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADSORPTION; ADULT; ANEMIA, HEMOLYTIC; ANTIBIOTIC PROPHYLAXIS; CEFOTETAN; CESAREAN SECTION; COOMBS' TEST; DRUG HYPERSENSITIVITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; POSTOPERATIVE COMPLICATIONS; PREGNANCY;

EID: 1442324864     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jones RN. Cefotetan: a review of the microbiologic properties and antimicrobial spectrum. Am J Surg 1988;155:16-23.
2. Fry DE. Cefotetan: a perspective for the surgical patient. Am J Surg 1988;155:108-10.
3. Noyes N, Berkeley AS, Freedman K, Ledger W. Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients. Infect Dis Obstet Gynecol 1998;6:220-3.
4. Gallagher NI, Schergen AK, Sokol-Anderson ML, et al. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion 1992;32:266-8.
5. Wagner BK, Heaton AH, Flink JR. Cefotetan disodium-induced hemolytic anemia. Ann Pharmacother 1992;26:199-200.
6. Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemia due to cefotetan. Transfusion 1992;32:269-71.
7. Ehmann WC. Cephalosporin-induced hemolysis: a case report and review of the literature. Am J Hematol 1992;40:121-5.
8. Chenoweth CE, Judd WJ, Steiner EA, Kauffman CA. Cefotetan-induced immune hemolytic anemia. Clin Infect Dis 1992;15:863-5.
9. Peano GM, Menardi G, Quaranta L, et al. A rapidly fatal case of immune haemolytic anemia due to cefotetan. Vox Sang 1994;66:84-5.
10. Eckrich RJ, Fox S, Mallory D. Cefotetan-induced hemolytic anemia due to the drug-adsorption mechanism. Immunohematology 1994;10:51-4.
11. Mohammed S, Knoll S, Van Amburg A, Mennes PA. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol 1994;46:369-70.
12. Moes GS, MacPherson BR. Cefotetan-induced hemolytic anemia: a case report and review of the literature. Arch Pathol Lab Med 2000;124:1344-6.
13. Ray EK, Warkentin TE, O'Hoski PL, Gregor P. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan. Can J Surg 2000;43:461-2.
14. Stroncek D, Procter JL, Johnson J. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction. Am J Hematol 2000;64:67-70.
15. Marques MB, Carr KD, Brumfield CG, Huang ST. A pregnant patient with sickle cell disease and cefotetan-induced immune hemolysis. Lab Med 2000;31:541-3.
16. Arndt PA. Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone - a case study approach. Immunohematology 2002;18:27-32.
17. Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;181:103-4.
18. Naylor CS, Steele L, Hsi R, et al. Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery. Am J Obstet Gynecol 2000;182:1427-8.
19. Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239-46.
20. Viraraghavan R, Chakravarty A, Szarfman A, Soreth J. Cefotetan-induced haemolytic anaemia: a review of 85 cases. Adverse Drug React Toxicol Rev 2002;21(1-2):101-7.
21. Garratty G. Target antigens for red-cell bound autoantibodies. In: Nance SJ, ed. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks, 1991:33-72.
22. Garratty G. Immune cytopenia associated with antibiotics (review). Trans Med Rev 1993;7:255-67.
23. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.
24. Gordon MC. Maternal physiology in pregnancy. In: Gabbe MC, Niebyl JR, Simpson JL, eds. Obstetrics, normal and problem pregnancies. Philadelphia: Churchill Livingstone, 2002;72-5.
25. Currier JS, Tosteson TD, Platt R. Cefazolin compared with cefoxitin for cesarean section prophylaxis: the use of a two-stage study design. J Clin Epidemiol 1993;46:625-30.